About Uma Bhatt
Form D filings for Stingray Therapeutics from 2023 to 2024 list Uma Bhatt as executive officer and director.
Uma Bhatt first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Uma Bhatt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Uma Bhatt works with at each company, as listed on that company's latest Form D.
Stingray Therapeutics, Inc. · Form D, May 14, 2024
JN
Jonathan Northrup
Chief Executive Officer and director
SS
Sunil Sharma
Executive officer and director